Laboratory Accounts Payable from 2010 to 2024
| LH Stock | USD 242.15 0.00 0.00% |
Accounts Payable | First Reported 1989-03-31 | Previous Quarter 760.6 M | Current Value 660.9 M | Quarterly Volatility 243.4 M |
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
Laboratory | Accounts Payable |
Latest Laboratory's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Laboratory of over the last few years. An accounting item on the balance sheet that represents Laboratory obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Laboratory are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Laboratory's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
Laboratory Accounts Payable Regression Statistics
| Arithmetic Mean | 522,478,333 | |
| Geometric Mean | 397,082,630 | |
| Coefficient Of Variation | 48.76 | |
| Mean Deviation | 207,846,444 | |
| Median | 621,300,000 | |
| Standard Deviation | 254,738,777 | |
| Sample Variance | 64891.8T | |
| Range | 857.7M | |
| R-Value | 0.95 | |
| Mean Square Error | 6148.3T | |
| R-Squared | 0.91 | |
| Slope | 54,397,946 | |
| Total Sum of Squares | 908485.8T |
Laboratory Accounts Payable History
About Laboratory Financial Statements
Investors use fundamental indicators, such as Laboratory's Accounts Payable, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 827.5 M | 868.9 M |
Currently Active Assets on Macroaxis
Check out the analysis of Laboratory Correlation against competitors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.